ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
Christian Dittrich(Leibniz Institute for Agricultural Engineering and Bioeconomy), Rainer Kunstfeld(Vienna General Hospital), Roisín M. Connolly(Johns Hopkins University), Jørn Herrstedt(Zealand University Hospital), Ahmad Awada(Centre Hospitalier Interrégional Edith Cavell), Christian Herold(Vienna General Hospital), Julia Close(University of Florida), Jean‐Pierre Lotz, Jennifer M. Duff(University of Florida), Alexander Kiss(University Hospital of Basel), Rossana Berardi(Marche Polytechnic University), Priya Gopalan(University of Florida), Fátima Cardoso(Breast Cancer Alliance), Paolo G. Casali(Fondazione IRCCS Istituto Nazionale dei Tumori), Dennie V. Jones(University of Florida), Sarah E. Coupland(University of Liverpool), Jan C. Buckner(McGill University), Andor W.J.M. Glaudemans(Boston University), Don S. Dizon(Dana-Farber Cancer Institute), Smita Bhatia(University of Alabama at Birmingham), Krisztián Homicskó(University Hospital of Lausanne), Linda Duska(University of Virginia Medical Center), Axel Grothey(Campbell Clinic), Luigi De Petris(Karolinska University Hospital), Alexandru Eniu(Institute of Oncology Prof. Dr. Ion Chiricuta), Elisabeth G.E. de Vries(Karolinska University Hospital), Pia Österlund(University of Helsinki), Nicholas Pavlidis(University of Ioannina), Susana Banerjee(Royal Marsden NHS Foundation Trust), Ulrich Keilholz(German Cancer Research Center), Jonas Bergh(Karolinska Institutet), Jan Bogaerts(European Organisation for Research and Treatment of Cancer), Edward Chu(Albert Einstein College of Medicine), Michael P. Kosty(Scripps Green Hospital), Marc S. Ernstoff(National Cancer Institute), Enriqueta Felip(Institut Català d'Ornitologia), Nicolas Girard(Institut Curie), Saad A. Khan(Aga Khan University), Maria De Santis(Medical University of Vienna), Diana L. Hanna(University of Southern California), Doug Pyle(American Society of Clinical Oncology), Jill Gilbert(Cancer Clinic), Nagi S. El-Saghir(American University of Beirut Medical Center), Stephen M. Hahn(The University of Texas MD Anderson Cancer Center), Martin F. Fey(European Union), Claus-Henning Köhne(Klinikum Oldenburg), S. Jezdic(European Society for Medical Oncology), Gunta Purkalne(Pauls Stradiņš Clinical University Hospital), Lorenz Jost(Kantonsspital Baselland Standort Bruderholz), Bertrand Coiffier(Unknown)
Cited by 129
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Photodynamic therapy of cancer: An update
|CA A Cancer Journal for Clinicians|2011|5.1k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Current and future burden of breast cancer: Global statistics for 2020 and 2040
|The Breast|2022|3.3k